Journal
CLINICAL INFECTIOUS DISEASES
Volume 50, Issue -, Pages S156-S164Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/651486
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Diseases [30036, 079590, 37856, 36973]
- Center for Global Health Policy
- Infectious Diseases Society of America
- HIV Medicine Association, through the Bill & Melinda Gates Foundation
Ask authors/readers for more resources
Recent epidemiological indicators of tuberculosis (TB) indicate that the Millennium Development Goal of TB elimination by 2050 will not be achieved. The majority of incident cases are occurring in population-dense regions of Africa and Asia where TB is endemic. The persistence of TB in the setting of poor existing health infrastructure has led to an increase in drug-resistant cases, exacerbated by the strong association with human immunodeficiency virus coinfection. Spreading drug resistance threatens to undo decades of progress in controlling the disease. Several significant gaps can be identified in various aspects of national-and international-directed TB-control efforts. Various governing bodies and international organizations need to address the immediate challenges. This article highlights some of the major policies that lawmakers and funding institutions should consider. Existing economic and social obstacles must be overcome if TB elimination is to be a reachable goal.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available